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Abstract
: As part of a coordinated effort to expand our research activityBackground
at the interface of Aging and Energetics a team of investigators at The
University of Alabama at Birmingham systematically assayed and
catalogued the top research priorities identified in leading publications in
that domain, believing the result would be useful to the scientific community
at large.
To identify research priorities and opportunities in the domain ofObjective: 
aging and energetics as advocated in the 40 most cited papers related to
aging and energetics in the last 4 years.
The investigators conducted a search for papers on aging andDesign: 
energetics in Scopus, ranked the resulting papers by number of times they
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Any reports and responses or comments on the
article can be found at the end of the article.
The investigators conducted a search for papers on aging andDesign: 
energetics in Scopus, ranked the resulting papers by number of times they
were cited, and selected the ten most-cited papers in each of the four years
that include 2010 to 2013, inclusive.
  Ten research categories were identified from the 40 papers. Results: 
These included: (1) Calorie restriction (CR) longevity response, (2) role of
mTOR (mechanistic target of Rapamycin) and related factors in lifespan
extension, (3) nutrient effects beyond energy (especially resveratrol,
omega-3 fatty acids, and selected amino acids), 4) autophagy and
increased longevity and health, (5) aging-associated predictors of chronic
disease, (6) use and effects of mesenchymal stem cells (MSCs), (7)
telomeres relative to aging and energetics, (8) accretion and effects of body
fat, (9) the aging heart,  and (10) mitochondria, reactive oxygen species,
and cellular energetics.
The field is rich with exciting opportunities to build upon ourConclusion: 
existing knowledge about the relations among aspects of aging and
aspects of energetics and to better understand the mechanisms which
connect them.
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Introduction
Energetics can be defined as the study of the causes, mechanisms, 
and consequences of the acquisition, storage, and utilization of 
metabolizable energy by biological organisms. The United States – 
indeed the world – is currently undergoing a crisis of excess energy 
storage, sometimes called the obesity epidemic. At the same time, 
the United States population is aging at an unprecedented rate with 
the over 65 population expected to double by 2050, the over 85 
population expected to triple, and the over 100 population expected 
to more than sextuple (U.S. Administration on Aging; http://www.
aoa.gov/Aging_Statistics/future_growth/future_growth.aspx#age). 
A consistent finding from ecology, basic laboratory science, and 
epidemiologic research is that aspects of energetics, including the 
perceived and actual availability of food, the ingestion of food, the 
composition of the food consumed, the amount of body energy 
accreted and expended, affect disease and disability, senescence, 
mortality rate, and longevity. A team of investigators at The Uni-
versity of Alabama at Birmingham (UAB) is currently aiming to 
advance innovative research at the interface of aging and energetics 
(hereafter A&E), and in preparation took stock of what ‘the field’ 
was describing as the vital research needs and opportunities in this 
domain. Realizing that the results of this assessment may be useful 
to others working in A&E, we publish them here.
Methods/Approach
Identification of the ‘Top 40’ Articles in A&E
To identify the ‘Top 40’ Articles in A&E, we conducted the follow-
ing search in Scopus: ((TITLE((aging OR ageing OR lifespan OR 
longevity OR senescence)) AND PUBYEAR > 2009 AND PUB-
YEAR < 2014) AND (TITLE((calori* OR diet* OR energetic* 
OR nutri* OR food OR fat OR adipo* OR “body composition”)) 
AND PUBYEAR > 2009 AND PUBYEAR < 2014)) AND (LIMIT-
TO(LANGUAGE, “English”)).
We then ranked the papers by number of times they were cited and 
selected the ten most cited papers in each of the four years that 
include 2010, 2011, 2012, and 2013. This ‘normalized’ for amount 
of time to be cited and resulted in a total of 40 papers (Appendix A).
Extraction of research priorities and themes
Ten of the authors then each reviewed 4 of the 40 top A&E pub-
lications and identified areas relative to A&E that were recom-
mended by the original papers’ authors as needs for future research. 
For example, we extracted statements from the publications that 
included phrases like “More studies are needed on…”, “Future 
work should…”, “Further studies are needed to …”, “…not yet been 
established …”, and so on. Thereafter, two authors (DBA and LHA) 
grouped these statements into thematic categories. This involved 
some subjectivity and loss of some recommendations which did not 
easily fit in any category, but seemed to capture the vast majority of 
the recommendations. The ten thematic categories were labeled: 1)
CR longevity response, 2) role of mTOR and related factors in lifes-
pan extension, 3) nutrient effects beyond energy (especially resver-
atrol, omega-3 fatty acids, and selected amino acids, 4) autophagy 
and increased longevity and health, 5) aging-associated predictors 
of chronic disease, 6) use and effects of MSCs, 7) telomeres rela-
tive to aging and energetics, 8) accretion and effects of body fat, 
9) the aging heart, and 10) mitochondria, reactive oxygen species, 
and cellular energetics. Specific suggestions often appeared in more 
than one category.
Narrative description
We now briefly summarize the recommendations in each category.
CR longevity response
Robustness and heterogeneity of the CR longevity response
It was in rats, in 1917, that caloric restriction (CR) was first docu-
mented to extend life1. In the decades following, researchers study-
ing model organisms as diverse as yeast, Drosophila, rodents, and 
primates have accumulated experimental evidence demonstrating 
that CR extends lifespan, slows the aging process, and/or improves 
healthy aging biomarkers2–4. Concurrently, repeated studies within 
select model species (e.g., rats) further supported the robustness 
of this response4. And thus, with this mounting evidence, the anti-
aging response to a protocol of 20 to 40% CR was largely con-
sidered to be a robust response, evolutionarily conserved across 
animals.
Intrigued by this perceived adaptive response to an obvious physi-
ological stress, researchers began traversing the animal lineage, 
beyond the traditional laboratory model organisms, to validate the 
robustness of this response. Instead they found extensive heteroge-
neity across species in their ability to extend median or maximum 
lifespan in response to CR4. Similarly, testing additional genetic 
strains of lab animals uncovered extensive variation in the response 
to CR within inbred, outbred, and wild-derived strains of nema-
todes and mice (currently over 80 strains tested)4–6. For example, 
while CR has a relatively robust response in rats and C. elegans, 
by causing nearly all strains tested to increase median or maximum 
lifespan (~30% increase in rats); in mice this is true for only a sub-
set of strains4. Rather, the effect of CR across mouse strains (par-
ticularly the ILSXISS) ranged from decreasing or having no effect 
to increasing lifespan, with an average increase of only ~15%4. 
Furthermore, this heterogeneity may be underplayed due to bias in 
reporting the negative effects of CR on lifespan4. Thus, despite the 
anti-aging response to CR being evolutionarily conserved, there is 
now considerable evidence for heterogeneity in either the presence 
or absence of the lifespan extension response, and the degree of the 
effect on lifespan.
Despite this variation, researchers are actively searching for con-
served molecular mechanisms underlying this response, typically 
using the short-lived model organisms. Many molecular mecha-
nisms are implicated in this response, but few have been or are 
found to be consistent across species. A generalized theme is that 
reprogramming of metabolism in the face of CR is key to achieving 
lifespan extension2.
The current challenge is to understand the sources of this hetero-
geneity and to determine if the underlying molecular mechanisms 
identified in the short-lived model organisms can translate to 
humans2. The heterogeneity of the CR response across mice strains 
depicts a role for genetic variation5. Some of the variation among 
strains is linked to the ability to regulate fat metabolism, thereby 
highlighting the link between body composition and aging5,7. The 
genetic variation also points to the possibility for natural selection 
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to act on this response, which may explain the heterogeneity across 
populations and species of non-model organisms. The variable 
results in repeated studies within a genetic strain points to excep-
tional sensitivity of the response to other environmental variables. 
Indeed mammals under CR are often more susceptible to patho-
gens and other environmental stresses (e.g., cold stress) which may 
vary among laboratories and studies4. Finally, heterogeneity among 
strains likely results from differences in gene by environment inter-
actions, such that the optimal CR protocol (e.g., level of CR, dietary 
composition, developmental timing of implementation, and consist-
ency of the regime) for producing anti-aging effects may be unique 
for each genetic background or population4,7.
One important question to consider is what one might call ‘forced 
inactivity’ and consequent low energy expenditure and any health-
span/lifespan consequences in caged laboratory animals. While 
there is substantial heterogeneity in volume of voluntary exercise 
across strains8, the main point is that lab mice will voluntarily run 
some amount (and up to 11 km/day) if given a wheel, and may reap 
healthspan benefits from it. The field as a whole may create ani-
mals (particularly rodents) predisposed to disease and early death 
because of forced inactivity (see, e.g., 9–11).
Overall, CR is the most discussed intervention for extension of life-- 
span. While largely, but not perfectly, evolutionarily conserved 
across animals, there is extensive heterogeneity in this response 
within and across species. Understanding the heterogeneity in the 
response to CR at both the organismal and molecular level will be 
essential for predicting the plausible effects of elements of a CR 
regime or its pharmaceutical mimics to heterogeneous human 
populations.
Mechanisms of the CR longevity response
Traditional thinking about CR, developed primarily with laboratory 
rodents, held that a significant restriction of dietary calories relative 
to ad lib feeding universally increased longevity and that energy 
intake alone, rather than the amount of any particular dietary nutri-
ent, modulated lifespan12,13. Recent research on an extended range 
of model organisms makes both of those general conclusions no 
longer tenable. Not only does the same CR regime that extends life 
in some genotypes of mice, flies, and yeast have no effect on longev-
ity in other genotypes14–16, it even shortens life in some genotypes 
indicating less than perfect evolutionary conservation17,18. Also, 
new evidence clearly indicates that restriction of some nutrients, in 
particular methionine or protein generally, is sufficient for signifi-
cant life extension across a range of organisms19–22. Consequently, in 
some cases, the term “CR” as a descriptor of a longevity-enhancing, 
reduced nutrient regime should probably be replaced with the 
more generic and previously widely-used term “dietary restriction 
(DR)”. The life-extending impact of nutrient reduction, where it is 
observed, can be reasonably referred to as the “DR effect”.
What can these new studies, employing a broader array of species, 
genotypes, and nutrient regimes than previously, suggest about 
mechanisms of life extension by dietary restriction? First, the lack 
of a life-extending effect, or even a life-shortening effect, of DR 
in some genotypes can be informative. For instance, in a series of 
recombinant inbred mouse strains, the ability of a strain to live longer 
under 40% CR was significantly heritable and related to metabolic 
efficiency5. Mice that lost the least weight and preserved the most 
body fat under reduced calories were most likely to live longer7. 
These results together suggest that allelic variation in energetic effi-
ciency genes may underlie the DR effect. Similarly, variation in 
replicative longevity in a series of 166 yeast single-gene deletion 
strains implicated vacuolar pH, superoxide dismutase activity, and 
mitochondrial proteome homeostasis (= proteostasis) as key deter-
minants of the response to DR. Follow-up studies in C. elegans, 
which has been evolutionarily separated from yeast for ~1 billion 
years, also implicate mitochondrial proteostasis in the DR effect18. 
Together these findings suggest a key role for energetic efficiency 
as a central process for understanding how nutrient intake and pro-
cessing affect health and longevity. Second, despite the promise of 
a unified, conserved mechanism for the DR effect suggested above, 
other evidence indicates more mechanistic variety. For instance, the 
growth hormone (GH)/IGF-1 axis is strongly implicated in the DR 
effect in mice such that: (1) reduced GH and IGF-1 signaling have 
been genetically associated with longer life, (2) DR in mice reduces 
signaling through these pathways, and (3) DR fails to increase lon-
gevity substantially in GH receptor knockout mice23. By contrast, in 
C. elegans insulin/IGF signaling is not required for the DR effect – 
at least under most DR regimes24. However, DR is implemented by 
at least 12 methods in worms, differing in the culture medium, food 
source, and the age at which restriction is initiated. Surprisingly, the 
genetic pathways implicated in the DR effect vary depending upon 
method, suggesting considerable mechanistic complexity for such 
a seemingly straightforward environmental manipulation.
What does this avalanche of new information on DR across species 
suggest for future research directions according to our most-cited 
recent papers? First, and with most consensuses, determining the 
impact on health and longevity of the relative intake of different 
nutrients as well as the timing and number of calories consumed 
needs refinement and re-evaluation across a range of species and 
genotypes2–4,17,25–30. However true, this suggestion lacks focus and 
more helpful perhaps is the linking by several papers of the DR 
effect either directly or indirectly to metabolic efficiency5,18,26 and 
the maintenance of proteostasis20,25,31,32. With respect to this latter 
process, the most commonly adduced mediator of proteostasis was 
modulation of mTOR activity2,25,26,32,33. Herein lies the most focused 
suggestion for future research to arise from our most-cited papers.
Role of mTOR and related factors in lifespan extension
The mTOR kinase integrates signals from nutrients, energy status, 
growth factors, and a variety of stressors and affects, among other 
things, the rate of protein synthesis and degradation via autophagy 
by a host of downstream effectors34. Thus TOR inhibition is a major 
player in the management of cellular energy and the maintenance of 
the proteome with aging. A number of our top-cited papers empha-
size that the link between health, aging, nutrition, and energetics 
would be dramatically advanced by increased knowledge of how 
various nutrient and caloric manipulations affect and integrate both 
upstream mediators and downstream effectors of TOR activity, par-
ticularly on a tissue-specific basis.
Rapamycin, a macrolide with immunomodulatory properties, and 
the product of the bacterium Streptomyces hygroscopius, was found 
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to inhibit an evolutionarily conserved protein belonging to the 
phosphatidyl inositol kinase-related serine/threonine kinase family, 
referred to as mTOR, the mechanistic target of rapamycin2,25,26,35. 
Modulating the mTOR signaling network affects mRNA translation, 
transcription, autophagy, ribosomal biogenesis, metabolism and cell 
survival, proliferation, cell size and growth, endoplasmic reticulum 
stress signaling, and other stress responses26. In mammals, CR, or 
reduced dietary protein or essential amino acid intake, can extend 
longevity, improve metabolic fitness, and increase stress resist-
ance, at least in part via inhibition of mTOR activity25. Nutrients 
(glucose, amino acids, especially leucine, and fatty acids) directly 
activate the mTOR pathway and also increase insulin levels, which 
can additionally activate mTOR35. mTOR acts as a major signaling 
hub, integrating multiple inputs and mediating the switch between 
growth and somatic maintenance to extend lifespan26. Mammalian 
cells have a single mTOR kinase which exists in two structurally 
and functionally distinct multiprotein complexes: mTORC1 and 
mTORC2. mTORC1 is acutely inhibited by rapamycin, although 
chronic rapamycin administration inhibits mTORC2 as well36. 
Amino acid deprivation is also a powerful inhibitor of mTORC1 
activity even the presence of acute growth factor stimulation25,26. 
Strong inhibition of mTORC1 early in life drastically slows or 
even stops development, but administration of rapamycin or other 
inhibitors of mTORC1 late in life causes lifespan extension, boosts 
immune function and rejuvenates hematopoietic stem cells25,26.
The specific upstream mechanisms directly responsible for amino 
acid sensing which are permissive of mTOR activation remains 
unresolved, but localization of the mTORC1 complex has emerged 
as an important aspect of amino acid mediated control25 (see Figure 1 
and Figure 2). The mTORC1 pathway controls protein synthesis 
most directly by phosphorylating and inhibiting a repressor of cap-
dependent mRNA translation, 4E-BP1. mTORC1 also regulates 
translation indirectly through activation of S6 kinase (S6K) whose 
substrate is the ribosomal protein S6, a component of the 40S ribo-
some important for translation26.
A drop in the cell’s energy content is reflected in the rise of the 
AMP/ATP ratio activating AMPK, which reduces the activity of 
mTORC1 by direct phosphorylation of TSC2 (Tuberous Scle-
rosis Complex 2), a negative regulator of mTORC1, and Raptor, 
an essential binding partner for the induction of translation by 
mTORC12,26. Biochemical evidence places AMPK upstream of 
mTORC1, but AMPK has also been shown to be downstream of 
S6K and can mediate S6K dependent effects on lifespan. Similarly, 
S6K is directly downstream of mTORC1, but via its inhibitory 
effect on IRS1 and 2, it is also upstream of mTORC1 via an insulin-
signaling route34. The complex biochemical interactions among the 
various players in the mTOR network clearly require more refined 
mechanistic investigation26. Thus, mTORC1, S6K and AMPK may 
constitute a complex feedback loop sensitive to dietary restriction 
which can redirect growth, metabolism and lifespan. In addition 
to nutrients and growth factors, appropriate control of growth also 
requires integration of information on environmental stresses. 
Osmotic stress, hypoxia, ER stress, genotoxic stress, mechanical 
forces, and contraction (e.g., muscle movement) may all regulate 
mTORC1 activity26.
Key questions that still need to be delineated are how multiple 
nutrients, growth factors and stress inputs are integrated into a 
single mTORC1 activity level; how the physiological responses 
downstream of mTORC1 are differentially regulated; how mTOR 
mediates changes in survival and lifespan in response to various 
environmental manipulations, especially nutrients; how the sex-
dependent effects of mTORC1 signaling on longevity are regu-
lated; with multiple mechanisms proposed; how mTORC1 activity 
couples nutrient availability to ribosome biogenesis; and which 
transcription factors involved in mediating stress responses are reg-
ulated by mTORC1 signaling to affect lifespan extension? Further-
more, the downstream effectors of mTORC1 are not sufficiently 
determined to understand which pathways are absolutely necessary 
for mTORC1’s role in lifespan extension. The role of mTORC1 is 
likely to be highly tissue specific, and the communication between 
cells, tissues, and organs to determine lifespan is a major knowl-
edge gap. Lastly, little is known about the role of mTORC1 in pri-
mate aging and life extension by CR in those primate populations 
in which such extension is seen2,25,26,28,35.
Nutrient effects beyond energy (especially resveratrol, 
omega-3 fatty acids, and selected amino acids)
In addition to the well-recognized effect of CR on longevity and 
disease, there is growing evidence that the abundance of individual 
nutrients, macronutrient types, and nutritional supplements (i.e., 
non-caloric dietary compounds) specifically influence health and 
longevity. For example, restriction of the essential amino acid, 
methionine, can improve health and increase longevity in mice 
and rats, although importantly too much restriction can compro-
mise health as well21,37,38. Methionine restriction provides benefits 
independent of caloric intake (i.e., with ad lib feeding). Although 
mechanistic differences are not fully understood, one possibility 
is that specific pathways sensitive to dietary nutrients can be tar-
geted to alter lifespan. Examples include amino acid signaling with 
the mTOR pathway, energy status sensing through the adenosine 
monophosphate kinase (AMPK) pathway, oxidative stress through 
SKN1/Nrf2, protein quality control though enhanced autophagy 
and the general stress response. A variety of perturbations may acti-
vate ‘longevity’ pathways such as these to promote better health.
There is also evidence accumulating that plant-based, bioactive 
compounds (phytochemicals) have a variety of cellular effects and 
also work through multiple pathways. While a focused approach is 
helpful for establishing cause-effect for individual compounds, it is 
becoming clear that we must understand combinations of dietary 
effects and their interactions to fully describe the biological com-
plexity underlying their contributions to homeostatic control and 
cellular regulation. For instance, one of the most well-known, and 
highly-researched CR mimetics (compounds which are proposed 
to mimic the benefits of CR without the necessity of energy intake 
reduction) is resveratrol, a polyphenol found in the skins of red 
grapes, muscadines, etc. Resveratrol is proposed to possess multiple 
agonist (sirtuins, AMPK) and antagonist (TOR/S6K, heat shock 
response) activities to pathways which have been genetically dem-
onstrated to mediate longevity and health outcomes. Yet, the effects 
of resveratrol remain open to question. Resveratrol has not yielded 
consistent results on longevity outcomes, but it remains a highly 
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Figure 1. Upstream of mTOR: classical and non-classical inputs. a | Growth factors such as insulin stimulate PI3K to generate 
phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3), which promotes the phosphorylation (P) of AKT at Thr308 by phosphoinositide-
dependent kinase 1 (PDK1). AKT phosphorylates tuberous sclerosis complex 2 (TSC2) on multiple sites to inhibit its GTPase-activating protein 
(GAP) activity for the small GTPase RAS homologue enriched in brain (RHEB). GTP-loaded RHEB then activates mammalian TOR complex 
1 (mTORC1). Growth factors also stimulate mTORC2 by promoting its association with ribosomes in a PI3K-dependent manner. b | Amino 
acids stimulate mTORC1 by promoting the conversion of RAS-related GTP-binding protein (RAG) heterodimers to the active conformation, in 
which RAGA or RAGB is loaded with GTP and RAGC or RAGD is loaded with GDP. c | In response to low energy (high AMP/ATP ratio), AMP-
activated protein kinase (AMPK) phosphorylates regulatory-associated protein of mTOR (RAPTOR) at Ser792 and TSC2 at Ser1387, leading 
to the inhibition of mTORC1. d | During the inhibition of the Hippo pathway component large tumour suppressor homologue (LATS) kinase, 
hypophosphorylated Yes-associated protein (YAP) translocates to the nucleus and promotes the expression of the microRNA miR-29. miR-29 
targets PTEN mRNA and inhibits PTEN translation, which leads to increased levels of PtdIns(3,4,5)P3 and the activation of both mTORC1 and 
mTORC2. Dashed arrows represent translocation of the molecule. e | Glycogen synthase kinase 3β (GSK3β) activates the TSC complex by 
phosphorylating TSC2 at Ser1379 and Ser1383. Phosphorylation of these two residues requires priming by AMPK-dependent phosphorylation 
of Ser1387. WNT signalling inhibits GSK3β and the TSC complex, and thus activates mTORC1. mTORC2 is activated by WNT in a manner 
dependent on the small GTPase RAC1. Proteins shown in green promote mTOR activity or their activity is promoted by mTOR. Proteins shown 
in red inhibit mTOR activity or their activity is inhibited by mTOR. Phosphorylation depicted in yellow is an activation signal and phosphorylation 
depicted in orange is an inhibitory signal. 4E-BP, eIF4E-binding protein; APC, adenomatous polyposis coli; GPCR, G protein-coupled receptor; 
GRB10, growth factor receptor-bound protein 10; IGF, insulin-like growth factor 1;IRS1, insulin receptor substrate 1; LRP, low-density lipoprotein 
receptor-related protein; mLST8, mammalian lethal with SEC thirteen 8; RICTOR, rapamycin-insensitive companion of mTOR; S6K, ribosomal 
S6 kinase; SIN1, SAPK-interacting 1; TBC1D7, TBC1 (TRE2–BUB2–CDC16) domain family member 7; ULK1, UNC-51-like kinase 1.
This figure has been reproduced with kind permission from Shimobayashi M, Hall M. Making new contacts: the mTOR network in metabolism 
and signalling crosstalk. Nature Reviews Molecular Cell Biology 2014;15:155–162.
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Figure 2. mTOR controls metabolism. Mammalian TOR complex 1 (mTORC1) promotes anabolic processes, such as the biosynthesis of 
proteins, nucleotides and lipids, and inhibits catabolic processes such as autophagy. Aa | mTORC1 phosphorylates (P) the hydrophobic motif 
(Thr389) in ribosomal S6 kinase (S6K), thereby activating it to subsequently phosphorylate ribosomal protein S6 at the sites indicated to promote 
ribosome biogenesis. mTORC1 also phosphorylates eIF4E-binding protein (4E-BP) at multiple sites to inhibit it. Inhibition of 4E-BP stimulates 
translation initiation, especially of 5′ oligopyrimidine tract (termed a 5′ TOP) and pyrimidine-rich translational element (PRTE) containing 
mRNAs. Ab | mTORC1 stimulates nucleotide and lipid synthesis. mTORC1 promotes the gene expression of key enzymes in the pentose 
phosphate pathway (PPP), at least in part by activating sterol regulatory element-binding proteins (SREBPs). mTORC1 also stimulates CAD 
(Gln-dependent carbamoyl-phosphate synthase, Asp carbamoyltransferase, dihydroorotase) by S6K-mediated phosphorylation at Ser1859, 
which leads to CAD activation and the stimulation of de novo pyrimidine synthesis. Furthermore, mTORC1 promotes lipogenic gene expression 
by activating S6K or by inhibiting the nuclear translocation of LIPIN1, both of which activate the transcription factor SREBP. Ac | mTORC1 
inhibits autophagy by phosphorylating UNC-51-like kinase 1 (ULK1) at Ser758 and ATG14 at multiple sites. During mTORC1 inhibition, AMPK 
phosphorylates ULK1 at Ser317, and thereby activates ULK1, which phosphorylates Beclin 1 in the vacuolar protein sorting 34 (VPS34)–Beclin 
1–ATG14 complex to initiate autophagy. mTORC1 also inhibits autophagy indirectly by blocking lysosome biogenesis, by phosphorylating and 
inhibiting the nuclear translocation of transcription factor EB (TFEB). B | mTORC2 co-translationally phosphorylates AKT at Thr450 to prevent 
its ubiquitylation and degradation. mTORC2 also post-translationally phosphorylates ATK at Ser473 to promote lipogenic gene expression by 
activation of SREBP1c. Moreover, mTORC2 co-translationally phosphorylates IGF2 mRNA-binding protein 1 (IMP1) at Ser181, which stimulates 
insulin-like growth factor 2 (IGF2) production. The activity of proteins shown in green is promoted by mTOR. The activity of proteins shown in 
red is inhibited by mTOR. Phosphorylation depicted in yellow is an activation signal and phosphorylation depicted in red is an inhibitory signal. 
Dashed arrows represent translocation of the protein. mLST8, mammalian lethal with SEC thirteen 8; PDK, phosphoinositide-dependent kinase 
1; RAPTOR, regulatory-associated protein of mTOR; RICTOR, rapamycin-insensitive companion of mTOR; SIN1, SAPK-interacting 1.
This figure has been reproduced with kind permission from Shimobayashi M, Hall M. Making new contacts: the mTOR network in metabolism 
and signalling crosstalk. Nature Reviews Molecular Cell Biology 2014;15:155–162.
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researched phytochemical that may mediate disease risk or cellular/
tissue health through other of these multiple interactions. Mice 
appear “largely unaffected by resveratrol”40.
An alternative approach to pathway specific targeting is exempli-
fied in omega-3 fatty acid research. Polyunsaturated fatty acids 
(PUFAs), which contain double bonds in their carbon backbone, can 
be subdivided in various families, with the ‘omega-3’ (double bond 
at the n-3 position) type PUFA garnering the most health claims. 
This may be related to the change in the structure and biochemical 
properties of the lipid that provides important components of cel-
lular membranes and protection from oxidative stress, particularly 
in the central nervous system where omega-3s are concentrated in 
nervous tissues. Although dietary deficiency has been associated 
with neurodegenerative disease risk and accelerated aging, supple-
mentation with omega-3s (above the accepted minimum require-
ment) to slow aging and reduce disease requires further testing. In 
fact it is a common conundrum in the nutrition/metabolism research 
field as to what constitutes nutritional deficiency or excess, and 
whether compensatory nutritional alterations (supplementation or 
restriction of the ‘required’ amount, or simply removing an ‘excess’ 
or ‘deficiency’) affect healthspan or lifespan. Thus, by definition, 
causes and mediators of aging require not just the alleviation of a 
disease inducing state, but promotion of a health maintaining state 
that reduces disease risk, while increasing health span and longevity. 
To help address this question, a recent study investigated the effect 
of macronutrient balance on longevity in mice by testing 10 diet 
compositions at 3 energy densities, and found that mTOR signaling 
responded to the dietary protein content (increased mTOR signal-
ing with more protein), raising the possibility that compounds like 
rapamycin which have significant longevity effects and alter amino 
acid signaling, may be modified by the background dietary protein 
and/or amino acid content. Alternatively, varied dietary composi-
tions having different macronutrient proportions, individual nutrient 
restrictions, impaired nutrient metabolism, etc. could be modified 
to reduce signaling through pro-aging pathways, thereby increasing 
health and longevity. Whether this is the underlying mechanism(s) 
by which CR exerts its varied health benefits requires future study. 
However, manipulations of the diet by compound inclusion or indi-
vidual nutrient restrictions, because they permit unrestricted intake, 
remains a type of intervention that more people will likely accept 
than CR as a change in their lifestyle.
Autophagy and increased longevity and health
Aging and senescence are associated with accumulation of damaged 
proteins and organelles, mitochondrial dysfunction, and metabolic 
imbalance, especially in post-mitotic cells41–48. These pathologies 
further exacerbate cell injury, resulting in organ failure and decreased 
lifespan. While the oxidative stress theory of aging has been 
explored, except in limited examples using gene knockout or over-
expression of antioxidant enzymes, there is a general lack of cor-
relation between the levels of antioxidants and lifespan49–55. Since 
proteins and organelles are normally cleared by the autophagy-
lysosomal activity, an emerging concept for regulation of aging and 
lifespan is that autophagy-lysosomal activity becomes deficient in 
aging32,56–67.
In general, it has been shown that autophagy is regulated at many 
levels, by nutrient availability, oxidative and reductive stress, 
hypoxia and pathogenic molecules68,69. When this activity is unable 
to meet the demand for clearance of damaged intracellular mac-
romolecules and organelles, pathologies emerge and progress. For 
example, perturbation of autophagy is evident in neurodegenera-
tive diseases including Alzheimer’s and Parkinson’s diseases70,71. 
In yeast, worms, flies, and mammals, insufficient autophagy con-
tributes to accumulation of protein aggregates and dysfunctional 
mitochondria, thereby leading to a decrease in lifespan and the 
pathogenesis and progression of various age-dependent chronic 
diseases56,57,59. In addition, inhibition of autophagy leads to deterio-
ration in mitochondrial function72,73; for example, ATG7-deficient 
skeletal muscles and pancreatic β cells accumulate dysmorphic 
mitochondria and exhibit defective oxidative phosphorylation73. In 
addition PINK1 knockout mice exhibit mitochondrial dysfunction 
in striatum, liver, brain tissue, and primary cortical neurons74,75.
In a complementary series of studies, a role for the beneficial effects 
of stimulating autophagy in healthy aging has emerged based on 
data from longevity studies in various models31,60–62,64,65,76,77. Rapa-
mycin, which inhibits mTORC1 activity and activates autophagy, 
has been shown to extend lifespan in several model organisms76–78. 
CR and resveratrol have also been shown to extend lifespan 
through SIRT1-mediated activation of autophagy in worms31, and 
genetic manipulations of autophagy also extend lifespan in animal 
models57,60,62,64,65.
While autophagy is an attractive therapeutic target for increasing 
life and health span, key questions remain regarding our under-
standing of the fundamental mechanisms of autophagic regulation, 
as well as the impact of autophagy activation on lifespan and health 
span. Investigations of these key questions are essential to our abil-
ity to fully exploit this pathway for improving healthy aging, lon-
gevity, and associated drug development.
One critical aspect is already clear – that the fundamental mecha-
nisms of autophagy regulation are context-dependent. For example, 
autophagic activation in response to oxidative stress is differentially 
regulated from autophagy activated by starvation. Determining the 
relevant common and specific autophagy mechanisms, and identi-
fying the signaling pathways that modulate the level, location and 
selectivity of autophagy, are crucial for a better understanding of 
autophagy in aging. Regarding our understanding of the impact of 
autophagy on aging, age-related disease and longevity, we must take 
into account that current animal studies are predominantly under-
taken using relatively pathogen- and nemesis-free environments. 
How we translate these studies to humans is still an unanswered 
question. Epidemiologic studies can give important clues in this 
regard, although pinpointing a specific contribution of autophagy 
on life and health span in human longevity studies remains a techni-
cal challenge.
An interesting and topical aspect is the extent to which individual 
variation in the autophagy pathway impacts healthy aging. Under-
standing the genetic variants in the human population which modu-
late autophagy is a largely unexplored aspect of genomic studies, 
yet will be essential as we enter the era of personalized health care.
Perhaps metabolomics, proteomics, or bioenergetics health indices 
need to be developed using imaging, accessible biopsies or body 
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fluid to provide the much-needed paradigm shifts in our understand-
ing of, and capacity for, monitoring human health conditions80–82. 
Additionally, autophagy activation may have differential impact on 
different organs in terms of their function and longevity. If improv-
ing health span is what we desire, then how to define health is not as 
simple as it appears. What one person defines as a healthy circum-
stance, another person may find unacceptable. Thus, we may have 
to be able to distinguish health and illnesses of different organs in 
any given person.
The emerging autophagy theory of aging holds tremendous prom-
ise, but is clearly a part of a bigger story, and integration into the 
existing paradigms should be considered at the outset. For exam-
ple, autophagy can be included into the metabolism theory of 
aging, which includes metabolism of metabolites, reactive spe-
cies, proteins, and organelles. Another example is the hormesis 
theory, which suggests that weak stress induces adaptive changes 
in the organism and may correlate with longevity30,48,55,82,83, thus, as 
Nietzsche opined, what does not kill you may make you stronger.
Aging-associated predictors of chronic disease
Expansion of adipose tissue during positive energy balance is a 
primary determinant of obesity and related pathophysiological 
sequalae84,85. In contrast to the long-held belief that pro-inflammatory 
signals exert a negative impact on metabolism, emerging studies 
suggest that proinflammatory signaling is required for adipose tissue 
remodeling and expansion85. In fact, impairments in the pro-inflam-
matory response of adipose tissue were shown to increase ectopic 
lipid accumulation, glucose intolerance and systemic inflammation. 
In a related fashion, adipose tissue acquires a pro-inflammatory and 
senescent-like state with aging independent of adiposity86. Although 
macrophage infiltration is thought to be responsible for much of 
the increase in inflammation with obesity, infiltration is lower with 
aging in the absence of obesity suggesting that pro-inflammatory 
responses to aging may be mediated to reduce ectopic lipid storage. 
Possible evidence for this, described in a recent review86, indicates 
that the pro-inflammatory cascade with aging in adipose tissue is 
mediated through preadipocytes. It is possible that progenitor turn-
over, higher fatty acid levels, and toxic metabolites may contribute 
to fat cell senescence which then increases release of pro-inflam-
matory cytokines, increasing the potential for senescence to spread 
locally from cell to cell. It is important to determine whether the 
pro-inflammatory cascade that occurs with aging is derived from an 
aging-induced attempt to sequester lipids in relevant adipose stor-
age sites as opposed to deleterious storage in ectopic sites such as 
skeletal muscle and liver.
As described in previous sections, CR extends lifespan in rodents 
and controversially in non-human primates as well29,87. At least part 
of the mechanism by which CR extends lifespan is through reduc-
tions in all-cause mortality. In fact, prolonged CR lowers body fat, 
slows rate of muscle loss, and lowers the incidence of neoplasia, dia-
betes, and cardiovascular disease in rhesus monkeys29. In addition, 
reproductive endpoints and brain morphology are preserved with 
CR. Since CR has been initiated at an early age in most studies, 
future studies are warranted to understand the effects of CR when 
initiated in adulthood. It is particularly important to understand 
the effects of CR following prolonged positive energy balance in 
adult rodents and non-human primates. Since recent human studies 
have suggested that exercise training can ameliorate the negative 
consequences of weight gain, it would be particularly beneficial to 
observe the effects of exercise training (forced or voluntary) during 
periods of CR and weight gain. Observation of mitochondrial func-
tion during these periods of CR and caloric surplus combined with 
either exercise training or no training would also be of great value.
Dietary restriction of the essential amino acid methionine has been 
shown to increase lifespan in rodents38 suggesting that restriction of 
total calories is not an absolute requirement for extending lifespan. 
While restricting fat and carbohydrate intake produces no exten-
sion of lifespan or improvements in markers of aging, improve-
ments in the quality of carbohydrate consumption may be involved. 
Along these lines, a lower glycemic index (GI) diet can attenuate 
blood glucose excursions, lower postprandial lipemia, and decrease 
inflammatory markers. This is critical as many of these processes 
have been linked to age-related macular degeneration (AMD) and 
other aging associated diseases. Recent work by Uchiki et al.88, 
using mouse and cell models, revealed that consumption of higher 
GI diets may increase risk for AMD and other aging diseases by 
increasing glycative stress-associated lesions in several different 
tissue compartments. The increase in advanced glycation end prod-
ucts (AGE) were due to a decrease in both the ubiquitin-proteasome 
system and lysosome/autophagy pathway, which are critical for 
degrading AGEs. Thus, it appears that one potential mechanism 
by which a higher GI diet can increase risk for AMD and other 
diseases is by altering cellular proteolytic activity. Future studies 
should be conducted to elucidate additional biological mechanisms 
by which consumption of a lower GI diet can promote health.
Use and effects of mesenchymal stem cells (MSCs)
Significant changes in fat mass and distribution occur during aging 
and the redistribution of adipocytes in the elderly has been linked 
with a number of age-related disorders. Notably, about 15–50% of 
the cells in adipocyte tissue comprise preadipocytes that give rise to 
fat cells89 and that play major roles in the mass and distribution of 
adipocyte cells during aging. Preadipocytes arise from adult stem 
cells in mammalian organs and one of the most important types of 
adult stem cell is the MSC. These are multipotent stromal cells that 
can differentiate into not only adipocytes, but also osteoblasts and 
chondrocytes as well as other cell types. Although MSCs have a 
high capacity for self-renewal, their ability to proliferate and differ-
entiate decrease during aging, and with increasing passage number 
in vitro90,91. Considerable interest has focused on the mechanisms 
of MSC proliferation and differentiation that may provide novel 
approaches for tissue regeneration, a cornerstone of advances in 
interventional aging research.
Recent work by Vidal et al.91 provides important insights into the 
senescence of MSCs that are central to organismal aging. To deter-
mine the potential use of MSCs in regenerative medicine, three 
different types of equine MSCs, bone marrow (BMSC), adipose 
tissue (ASC) and umbilical cord tissue (UCMSC), were evaluated 
for onset of cellular senescence in culture which has direct implica-
tions in their use for regenerative measures during aging, especially 
of fat and bone. It was discovered that BMSCs senesce after fewer 
population doublings than ASCs and UCMSCs demonstrating the 
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more limited use of these types of MSCs for tissue regeneration. 
This also suggests that adipose and umbilical cord tissue may be 
preferable for tissue banking purposes although further studies on 
MSCs from different tissue sources are sorely needed in order to 
fully elucidate the potential for future therapeutic strategies in tis-
sue repair during aging92. Potential differences in methodology, 
however, could account for some of the reported results of limited 
capacity of BMSCs for tissue regeneration and additional studies 
will be required for optimization and standardization of cell culture 
conditions for the different types of MSCs. Also, yet unsolved is the 
differentiation potential of the various MSCs (BMSCs, ASCs and 
UCMSCs) at higher passage, since loss of differentiation potential 
could severely limit their ability to create new tissue for regenera-
tive medicine and their application in the elderly.
A number of intriguing questions have arisen with respect to the 
mechanisms responsible for the attenuation of MSC proliferation 
and differentiation potential during aging. Among these remain-
ing enigmas is whether senescence can occur at any stage of life86, 
which is clearly important with respect to the role of MSCs dur-
ing aging. It is also not yet clear if senescence can spread from 
cell to cell in fat tissue in vivo or whether cellular senescence is a 
key cause for metabolic dysfunction secondary to age- and obesity- 
related changes in adipose tissue86. Future studies will also need 
to be directed toward determining if a senescence-like state can 
develop in terminally differentiated cells. Although there are sug-
gestions that all of these venues are important with respect to 
MSCs, considerable additional research will be required before the 
role of MSCs in aging and their potential in tissue regeneration can 
be fully appreciated.
As aforementioned, MSCs are preadipocyte cells that give rise to 
new fat cells. The MSC progenitor cells can produce osteoblasts 
as well as macrophages that produce mesenchymal adipocyte-like 
default (MAD) cells important in age-related fat tissue redistribu-
tion and metabolic dysfunction. However, the variation in mac-
rophage content during aging in subcutaneous fat tissue has shown 
little change while changes were noted between age and percent 
of macrophages in human omental adipose tissue92. This suggests 
that additional studies are required and that MSCs and subsequent 
macrophage distributions and abundance during aging among fat 
deposits will require considerable future investigation.
Lastly, MSCs are also central to bone marrow fat during aging and 
in age-related diseases such as diabetes. It is noteworthy that fat 
occupies a significant proportion of bone marrow; although its role 
in aging and age-associated disease is not well understood. A recent 
investigation by Krings et al.93 suggests that important changes 
occur in bone marrow fat not only during aging, but also in diabetes. 
MSCs give rise to different types of fat such as brown and white 
adipose tissue (BAT and WAT, respectively) and the metabolic phe-
notypes of bone marrow fat have characteristics of both types of adi-
pose tissue. It was found that a decrease in BAT-like characteristics 
with aging and diabetes may contribute to age-related loss of bone 
remodeling and hematopoiesis that could have important implica-
tions in a number of changes that occur with aging secondary to 
the dynamics of MSCs in bone marrow93. This may create avenues 
for therapeutic interventions for bone integrity during aging and in 
age-associated diseases in addition to regenerative medicine possi-
bilities for skeletal tissue. However, future studies will be required 
to determine the role of MSCs in bone marrow during aging and 
metabolic diseases especially with respect to their lineage identity 
and differential adipose content in bone marrow.
Taken together, although a number of studies have eloquently 
revealed many of the roles of MSCs with respect to aging and age-
related diseases, there are many avenues for additional studies to 
further reveal (1) the dynamics of cellular senescence in vivo and 
how this may limit potential for regenerative medicine approaches, 
(2) the behavior of MSCs from different tissue sources during 
aging, (3) the mechanisms for senescence of MSCs and how this 
impacts not only the aging process itself, but advances in inter-
vention of aging and age-associated diseases, (4) the distribution 
and abundance of MSCs and macrophages during aging among fat 
depots, and  (5) the role of MSCs in bone marrow and the impor-
tance of MSCs in contributing to maintenance of skeletal integrity 
in the elderly. Clearly many important advances have contributed 
significantly to our understanding of MSCs and their roles in aging; 
although many key questions remain that will provide fertile ground 
for future investigations.
Telomeres relative to aging and energetics
Telomeres, the repetitive sequences at the end of chromosomes that 
buffer the genetic coding regions, suffer from attrition during suc-
cessive cycles of DNA replication and cellular division. The telom-
erase enzyme, responsible for the maintenance of telomere length, 
is thought to be active in germ-line cells, but relatively inactive in 
differentiated tissues in humans. Thus, the gradual erosion of the 
chromosome ends is proposed to contribute to genetic instability 
and loss under conditions of replicative stress and over the course 
of life94. When a critically short telomere length is reached, the cell 
enters replicative senescence and can no longer contribute to regen-
erative needs of the particular tissue95.
Telomere length is variable between individuals at birth and with 
the proliferative demands of different body tissues, telomere length 
can vary between tissues within an individual94. Previous research 
has shown that shortened telomeres are associated with a number of 
metabolic- and age-related pathologies (e.g. oxidative stress, inflam-
mation) and diseases (cardiovascular, diabetes, cancer, obesity)96–99. 
Controlling for individual variations in telomere length by using 
intra-individual telomere length, estimated attrition is further asso-
ciated with potential contributors insulin resistance, a proposed 
mediator of metabolic-related disease and aging100.
From a broader comparative perspective, humans have relatively 
short telomeres yet age more slowly and live significantly longer 
than other mammals. Despite these interspecies differences, the 
observed associations between telomere length and attrition suggest 
there may be additional information to be learned by understanding 
the physiologic contributors to telomere attrition that overlap with 
aging modulation. In this regard, a recent review discussing the 
obesity-mortality association has highlighted a number of gaps in 
the current knowledge99. For instance, there is a known association 
between excess body weight as measured by body mass index (BMI) 
and morbidity/mortality, yet there are exceptions where individuals 
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with high-BMIs can have better than average health outcomes. 
Whether this BMI-mortality association is due to inter-individual 
differences in cellular aging rates, which may be captured through 
monitoring telomere change with body mass change, remains to 
be seen. Similarly, within individuals, whether telomere attrition 
is a composite outcome of age-sensitive biological mediators (oxi-
dative stress, inflammation) that would reliably predict morbidity 
and mortality remains to be demonstrated. Along this same line, 
longitudinal studies of telomere dynamics within specific interven-
tions to accelerate or retard aging (e.g., high fat diet feeding vs. 
dietary restriction), and including early life exposures and late-life 
health outcomes to better understand the “early life programming” 
effect in disease risk, could be informative. Such studies should 
include measures of caloric intake, energy balance, body composi-
tion, non-caloric nutritional factors associated with telomere length 
maintenance, stress exposure/protection, and co-morbidities in the 
outcomes. For the present, there is strong consensus that telomere 
shortening can contribute to cellular health and replicative capac-
ity, and telomere length is correlated with a number of energetic- 
and age-associated negative health outcomes. Although it is not yet 
clear that telomere length or attrition is causative in these cases, 
particularly for mortality in humans, future research will require 
identifying the most relevant metric of telomere length (shortest 
single chromosome telomere length vs. population mean or over-
all distribution, etc.) and using such information to assess whether 
telomere attrition is more of a biomarker or causative factor in age-
related phenotypes.
Accretion and effects of body fat
Aging is generally associated with increases in total adiposity as well 
as waist circumference despite a lack of change or even a reduction 
in body weight (or concomitant decreases in lean mass)37,101. Posi-
tive energy balance, as resulted from subtle decreases in physical 
activity and basal metabolic rate that are not matched by decreases 
in energy intake, is suggested to be the cause for this increased 
adiposity101. During advanced old age, while total amount of fat 
mass tends to decline or remains stable, fat is redistributed from 
subcutaneous to intra-abdominal visceral depots and to ectopic 
sites, including muscle (cardiac and skeletal), liver and bone mar-
row86,89. Fat redistribution and fat tissue dysregulaton with aging 
occurs across species and is associated with age-related diseases, 
lipotoxicity, changed metabolic variables and reduced longevity, 
with some of these changes more closely related to regional adipose 
tissue distribution than total fat mass89,93. These changes might be 
explained by the increased systemic free fatty acid exposure caused 
by impaired capacity of fat tissue to store lipid89. Total or regional 
fat distribution with aging could have influence on morbidity and 
mortality risk, for example the removal of visceral fat significantly 
prolonged lifespan in rats101,102. In humans, weight gain and visceral 
adiposity is strongly associated with diabetes, atherosclerosis, 
thrombiosis, hypertension and other age-related diseases103. It is 
also notable that there appears to be protective effects of aerobic 
fitness on all-cause mortality, even at high levels of adiposity. Poor 
aerobic fitness is a powerful predictor of all-cause mortality across 
a wide BMI range104,105.
Brown adipose tissue (BAT), which is related to thermal dysregula-
tion and energy imbalance, decreases with aging in both animals 
and humans89. However, it is unclear whether the decline in BAT is 
related to the white adipose tissue changes with aging. With aging, 
midfacial fat compartments have an inferior migration and volume 
shift106.
Preadipocytes, comprising a significant proportion of cells in adi-
pose tissue, are constantly giving rise to new fat cells throughout 
life, but with aging they are less capable of accumulating lipid than 
are cells from younger individuals, which may contribute to the 
increased abundance of small, insulin-resistant, dysfunctional fat 
cells89. Preadipocytes also have decreased replication and adipo-
genesis, and increased proinflammatory cytokines and susceptibil-
ity to lipotoxicity with age86.
Fat, which was once thought of as a largely biologically inert lipid 
storage depot, also plays an important role in the regulation of 
energy metabolism, thermoregulation, inflammation, and immune 
responses that is implemented through a number of adipokines 
derived from adipose tissue2,93. Adiponectin, a cytokine primarily 
originating from adipose tissue, has been shown to negatively cor-
relate with many age- and obesity-related diseases and positively 
correlate with longevity in mice107,108. Similarly, leptin, which has 
been shown to modulate total body fat and visceral fat distribution, 
might play a causative role in the metabolic decline in aging inde-
pendent of fat mass109,110. As in obesity, aging is frequently asso-
ciated with increased fat tissue and circulating pro-inflammatory 
cytokines secreted by dysfunctional fat cells, including tumor 
necrosis factors-α (TNF-α) and interleukin (IL-6)86, which in turn 
alter T lymphocyte subsets and attract mast cells and cause mono-
cyte recruitment and macrophage activation89. Macrophages infil-
trate adipose tissue of obese animals and humans more extensively 
in visceral fat than subcutaneous fat. Animal studies show mac-
rophages and pro-inflammatory factors increase with aging mainly 
in subcutaneous fat but remain constantly high in visceral fat 
throughout life, which implicates that subcutaneous fat gets dysfunc-
tional with aging, potentially contributing to fat redistribution86,89.
Under CR, proportionally more body fat is lost than other tissue, 
which may contribute to alterations in systemic metabolic homeo-
stasis, influencing factors at the interface of metabolism and inflam-
mation37. In aging studies utilizing non-human primates, CR lowers 
body weight, decreases fat mass and improves insulin sensitivity29,37. 
One of the most striking effects of CR in non-human primates is the 
impact on body composition, especially fat mass in the abdominal 
region29. A study on rats has shown that CR improves carbohydrate 
metabolism in aging by decreasing visceral fat111. Thus it is sug-
gested that interventions that stimulate metabolism and/or activate 
WAT signaling hold great promise as mimics of CR37. However, 
it is not clear yet whether CR is as effective in non-overweight 
individuals or certain stages of lifespan. Furthermore, it is advis-
able to titrate allocations in already fat-depleted animals in order to 
guard against drawing on lean tissue for energy since food intake 
steadily declines after middle age29.
The aging heart
Although other organs were discussed in the top 40 papers that we 
reviewed, the heart received particular emphasis. Congestive heart 
failure is an age-associated disease and is the direct result of defective 
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cardiac aging112. The results from these studies suggest that fibrosis 
is a common consequence of myocardial infarction (MI) in older 
adults, but less common in younger adults113. The heart is a complex 
organ beating non-stop and is composed of 2 main cell types, car-
diomyocytes and fibroblasts, along with pacemaker cells, Purkinje 
fibers, smooth muscle cells, resident macrophages, endothelial and 
epicardial cells, and a pool of resident stem cells. With aging, cardi-
omyocytes tend to either develop hypertrophy or wear and tear lead-
ing to necrosis. Fibroblast dysfunction with age leading to fibrosis, 
primarily contributes to diastolic heart failure in elderly individu-
als. Following a heart attack aging fibroblasts fail to develop stable 
scars and there is extensive left ventricle dilation and reduced sur-
vival in aging rodents and elderly individuals113,114. Novel strategies 
are required to reduce wear and tear in cardiomyocytes and pre-
serve fibroblast function in order to form mature matrix in left ven-
tricle remodeling in aging. Therapies are under investigation that 
stimulate cardiomyocyte regenerative capacity and limit fibrotic 
progress, but in the majority of cases, aging, the main confounding 
factor, is ignored.
Hypertension is highly associated with aging and congestive heart 
failure. Congestive heart failure significantly reduces cardiac out-
put and limits functional capacity and quality of life. Age-related 
increases in the PR (PQ) interval (> 200 ms; distance on an ECG 
from the start of electrical conduction in the atria (beginning of p 
wave) to the start of electrical conduction in the ventricles (begin-
ning of q wave) are positively associated with increased incidence 
of heart failure115. The relationship between ECG P
wave
 to R
wave
 
interval (PRI) and heart failure has important clinical implications 
suggesting that monitoring of PRI may be a cost-effective strat-
egy to identify individuals at increased risk for adverse outcomes 
associated with aging. Additional large-scale studies are needed to 
more precisely identify the magnitude of PRI prolongation over the 
lifespan. Future human studies should incorporate younger partici-
pants to elucidate the relationship between PRI and heart failure. 
In addition, an important area of investigation will be to determine 
if lifestyle interventions such as exercise and/or energy restriction 
(in the presence or absence of weight loss) reduces age-associated 
prolongation of PRI and subsequent incidence of heart failure and 
atrial fibrillation. Further validation with echocardiographic data 
such as chamber size and left ventricular mass are also crucial for 
clinical utility of the PRI in predicting adverse outcomes in multiple 
race/ethnicities.
Control of inflammation is a widely studied approach for the treat-
ment of MI, based on evidence from population-based studies. 
These studies suggest a direct role of inflammatory cytokines such 
as IL-6 and TNF-α on heart failure development116. Over the last 
thirty years, use of anti-inflammatory treatments has been discouraged 
for the treatment of post-MI inflammation in heart failure pathol-
ogy. The reason for this is that studies with older animals indicate 
that aberrant inflammatory responses – either defective or overac-
tive –are associated with worse outcomes, in particular reduced 
collagen deposition in response to injury. Interestingly, the reverse 
of what is observed in young animals. Therefore, an anti-fibrotic 
or anti-inflammatory strategy needs to be used with caution in 
older individuals. For example, methyl prednisolone treatment has 
been reported to cause ventricular rupture in humans and specific 
cyclooxygenase 2 inhibitors in fact induce more MI events. TNF-α 
trials too have so far failed to meet the expectation of cardiolo-
gist for heart failure treatment117–119. Thus, in the last three decades 
anti-inflammatory approaches have not been shown to be effective. 
Therefore, novel targets with a major focus on the resolution of 
inflammation are necessary.
Lindsey et al.120 showed that aging alters extracellular matrix remod-
eling and observed that middle aged (15 month-old) and older (23 
month-old) CB6F1 mice had increased soluble protein fraction and 
decreased insoluble collagen compared to young mice. These struc-
tural changes are accompanied by increased end-diastolic dimen-
sion and ventricular wall thickness in aging mice with increased 
metalloproteinases (MMPs-3,8,9,12) and decreased inhibitory fac-
tors (TIMPs-3 and 4) expression. Thus, functional and proliferative 
capacites of fibroblasts are essential to maintain degraded matrix 
and to ensure that the structural integrity of the left ventricle is 
maintained in aging120.
Age-related increases in fibrosis are also observed in C57Bl/6J 
sarcopenic and aging mice. Senescent (~32 month-old) C57BL/6J 
mice developed left ventricle structural changes characterized as 
interstitial fibrosis leading to increased left ventricular end diastolic 
dimension, decreased wall thickness, and decreased ejection frac-
tion, indicating reduced contractile performance due to fibrosis.
Thus, collectively preventative strategies are required to prevent 
ventricular fibrosis in aging121. While developing prevention strat-
egies, the post-MI therapeutic treatments are needed to maintain 
survival of cardiomyocte and preserve fibroblast function mainly 
focusing on resolution of inflammation rather than inhibition in the 
reparative phase of remodeling of the aging heart.
Mitochondria, reactive oxygen species, and cellular 
energetics
Denham Harman originally proposed the “free radical theory of 
aging” in 1956, which was later refined to the “mitochondrial theory 
of aging” in 1970’s. The common theme in both was that oxida-
tive damage accumulates with age; inclusion of the latter implicated 
reactive oxygen species generated by mitochondria as the primary 
source of this stress. This theory has been intensively explored 
– some studies have provided results consistent with this theory, 
whereas the majority has not. For example, in some cases oxida-
tive stress increased lifespan, and other reports have shown that 
increased mitochondrial DNA (mtDNA) mutation associated with 
decreased function, without a concomitant increase in oxidative 
stress, is sufficient for generating a premature aging phenotype. At 
the inception of both these ideas the central paradigm for the free 
radical field was “oxidative stress” in which the simple concept was 
that the aging was accelerated by an imbalance between oxidants 
and antioxidants. The hypothesis was later refined to encompass data 
that suggested that mitochondrial superoxide and hydrogen perox-
ide were uncontrolled “leaks” from electron transfer and mitochon-
dria were the major source of reactive species in the cell. Since the 
1970’s it is clear that both concepts are not supported by experimen-
tal evidence and cannot encompass the role of reactive species such 
as hydrogen peroxide, nitric oxide and electrophilic lipids as cell 
signaling molecules71,122,123. Mitochondria are clearly not the major 
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source of reactive species in the cell and whole families of proteins 
have now been discovered which show the controlled production 
of superoxide, nitric oxide, hydrogen peroxide and other reactive 
species with which the mitochondria interact in cell signaling cas-
cades122,124–126. Consequently, mitochondrial function may prove to 
have a more critical role in aging, not because of its generation of 
damaging ROS, but because of its role in cell signaling.
It is instructive to consider the evolution of mitochondria, which are 
ancient bacterial symbionts with their own genetic and protein syn-
thesis systems, to understand the fundamental nature of mitochon-
drial signaling to the cell, sometimes called retrograde signaling127. 
Each cell can contain hundreds to thousands of mitochondria each 
of which contains multiple copies of mtDNA. The mtDNA encodes 
genes essential for electron transport and oxidative phosphoryla-
tion. A unique aspect of mitochondria is that the proteins required 
for its multiple functions are encoded by both nuclear and mito-
chondrial genomes, requiring coordination and communication 
between the two cellular compartments. While reminiscent of its 
endosymbiotic origins, the mitochondrion retained many of the 
catalytic subunits required for electron transport and ATP synthase 
in its mtDNA. Hence, any mutation within the mtDNA has the 
potential to modify mitochondrial bioenergetics. In this respect, it 
has been proposed that prehistoric mutations in the mtDNA modu-
lated the economics of mitochondrial production in the interrelated 
functions of ATP (energy), heat (thermoregulation), and superoxide 
(which can be converted to H
2
O
2
 and act as a signaling molecule) 
production, enabling our ancestors to successfully establish popula-
tions northward as they migrated from Africa. MtDNA mutations in 
northern migrants decreased caloric utilization for ATP generation 
while increasing that used for generating heat, creating a metabolic 
advantage for survival in colder climates. Although decreasing 
mitochondrial economy (in terms of ATP generation per calorie 
consumed), these changes were accommodated by changes in diet 
(increased caloric intake associated with animal fats). By com-
parison, mtDNA mutation that increased caloric utilization for ATP 
(thus decreasing energy lost to heat production) would be better 
adapted to low calorie diets and warmer climates (e.g., sub-Saharan 
Africa). In contemporary society, these prehistoric adaptations of 
mitochondrial economy can affect mitochondrial health and influ-
ence susceptibility to age-related disease in a setting of chronic 
positive energy balance72,128. In support of these concepts are molec-
ular epidemiologic studies that correlate both human longevity and 
disease risk with certain mtDNA polymorphisms. More recently, it 
has been shown that mtDNA can directly influence susceptibility to 
heart failure and hepatic steatosis in mice, consistent with concepts 
of mitochondrial – nuclear genetic interactions129. Hence, the role 
of the mitochondrion in aging is most likely multi-faceted due to its 
multiple cellular functions that include bioenergetics and signaling. 
More recently, studies have implicated mtDNA as a DAMP (dam-
age associated molecular pattern) broadening its cellular functions 
to include immune response. The focus in the redox biology field 
has now shifted to understand why and how the “quality” of the 
mitochondrial population in cells declines with age and integrates 
concepts from autophagy, cell signaling and bioenergetics71,130,131. 
Of particular interest is autophagy and mitochondrial biogenesis 
since they are both biological pathways that can link CR with 
healthy aging and bioenergetics37,132.
Hence, assessment of mitochondrial health in a dynamic fashion 
in our aging populations may provide a means for understanding 
the basis and progression of many forms of age-related diseases, 
including neurodegenerative diseases, diabetes, cardiovascular dis-
ease, liver disease, and cancer. This has now become possible with 
the development of measures of bioenergetic health from the leuko-
cytes and platelets isolated from human subjects133,134.
Conclusion
In conclusion, across forty of the most cited papers at the interface 
of aging and energetics published in the last four years, we were 
able to identify ten major themes of research suggestions. We have 
summarized them here for the interested investigator.
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In order to make conclusions about the current consensus on mechanisms involved in the very broad field
of aging and energetics (broadly defined as the acquisition, storage and utilization of metabolizable
energy by biological organisms), the authors have utilized a novel methodology for determining what
researchers regard as the top 40 relevant publications over the period of 2011 through 2013, as
ascertained via a broad search algorithm and ranked by the number of citations over that time period.
Their analysis of these selected papers provide an interesting selection of some ten overlapping domains,
including such ”old timers” as caloric restriction (now more accurately referred to as dietary restriction)
and the new star of the field, mTOR signaling.
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algorithm. Such an exercise has the potential to reveal highly novel ideas that, perhaps 10 or so years
from now, could result in a new flowering of publications that might transform some segments of this
exceedingly complicated family of nature-nature interactions. 
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Here, the authors summarize 40 of the most widely-cited papers on energetics and aging over the last 4
years by themes, including suggested priorities from those publications for future work. Overall, I think this
article does a good job of highlighting and summarizing state-of-the-art aspects of several broad and
complex topics. Discussion of the heterogeneity of the caloric restriction (CR) response was particularly
warranted. The implementation and interpretation of CR studies requires careful consideration of among
things, the intervention timing (early or later in life), diet quality, the control group (  or mildlyad libitum
restricted) as well as the dose. Indeed, some strains that respond negatively to 40% CR, may respond
differently at lower levels of restriction, in part due to reasons alluded to by the authors when discussing
the potential risk of further fat depletion in already lean animals or humans. The authors also highlight
some important recent observations regarding the role of specific nutrients (methionine) and botanical
compounds (resveratrol) on aging, that do not involve calories  . Of note, this has been furtherper se
supported by a recent study that did not make the list ( ), linking protein intake withLevine  ., 2014et al
IGF-1 levels, cancer and mortality risk in younger, but not older humans.
Specific cellular mechanisms of interest are also discussed, with a particular emphasis on mTOR
signaling in modulating organismal aging, and its interplay with nutrients and hormones. Rapamycin
studies have driven much of the interest in this area, but metformin, which is not discussed here, is
frequently and safely used clinically to treat diabetes, and may act in part via similar pathways, and has
been linked to less cardiovascular disease, cognitive decline, cancers and improved survival in humans
(see  ). Overall, this is a well conceived and timely review of recent highly-citedBannister et al.,  2014
papers linking aging and energetics that deserves revisiting in another 4 years.
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This is an interesting manuscript describing top research priorities in the aging and energetics field based
on ideas extracted from recent papers. The title and abstract are appropriate and represent the
information presented in the body of the manuscript. The basis of the paper is atypical in that the data
generated are not assay-based but literature-based. The design is again, different but reasonable based
on the outcomes to be generated. The data generated are ranked to identify the most highly cited papers
in the past 4 years (2009<2014) and then further narrowed to 40 highly cited papers. The authors
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in the past 4 years (2009<2014) and then further narrowed to 40 highly cited papers. The authors
identified the top ten areas related to aging and energetics focusing on recommendations within these
papers as to where further work should be focused. These areas included the CR longevity response,
nutrient effects beyond energy, autophagy, mitochondria, ROS and cellular energetics and
age-associated predictors of chronic disease among others. The recommendations for continued work in
the areas covered were directed, insightful, and addressed strengths and weaknesses of the published
studies and the area in general. Overall, the manuscript was well-written and provided important direction
to those in the field in a relatively unbiased manner.
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